Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 400 (Q44754243)
Jump to navigation
Jump to search
scientific article published on 4 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 400 |
scientific article published on 4 November 2013 |
Statements
1 reference
Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 400 (English)
1 reference
Narikazu Boku
1 reference
Ichinosuke Hyodo
1 reference
Shuichi Hironaka
1 reference
Shinya Ueda
1 reference
Hirofumi Yasui
1 reference
Tomohiro Nishina
1 reference
Masahiro Tsuda
1 reference
Takehiko Tsumura
1 reference
Naotoshi Sugimoto
1 reference
Hideki Shimodaira
1 reference
Shinya Tokunaga
1 reference
Toshikazu Moriwaki
1 reference
Taito Esaki
1 reference
Michitaka Nagase
1 reference
Kazumasa Fujitani
1 reference
Kensei Yamaguchi
1 reference
Takashi Ura
1 reference
Yasuo Hamamoto
1 reference
Satoshi Morita
1 reference
Isamu Okamoto
1 reference
4 November 2013
1 reference
1 reference
Identifiers
1 reference